To assess the correlation between USP14 and IDO1 levels in clinical CRC samples, we performed IHC in 42 specimens with low levels of USP14 and 77 specimens with high levels of USP14 (Fig. 7a). This evidence concerns the gene USP14 and colorectal carcinoma.